Platelet Derived Growth Factor Expression, Myelofibrosis and Chronic Myelogenous Leukemia

References

• Lichtman M.A. Chronic myelogenous leukemia and related disorders. Hematology, W.J. Williams, E. Beutler, A.J. Ersley, M.A. Lichtman. McGraw-Hill, New York 1990; 202–223
   Google Scholar
• Kantarjian H.M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: a concise update. Blood. 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• Speck B., Bortin M.M., Champlin R., Goldman J.M., Herzig R.H., McGlave P.B., Messner H.A., Weiner R.S., Rimm A.A. Allogenic bone–marrow transplantation for chronic myelogenous leukaemia. Lancet 1984; i: 665–668
   Google Scholar
• Yoffe G., Chinault A.G., Talpaz M., Blick M., Kantarjian H.M., Taylor K., Spitzer G. Clonal nature of Philadelphia chromosome positive and negative chronic myelogenous leukemia by DNA hybridization analysis. Exp Hematol 1987; 15: 725–729
   PubMed Web of Science ®Google Scholar
• Bentley S.A. Biology and pathology of bone marrow connective tissue. Myelofibrosis, Pathophysiology arid Clinical Management, S.M. Lewis. Marcell Dekker, New York 1983; 87–96
   Google Scholar
• Gay S., Gay R.E., Prchal J.T. Immunohistochemical studies of bone marrow collagen. Myelofibrosis and the biology of connective tissue, R. Alan. Liss, Inc., New York 1984; 291–306
   Google Scholar
• Deuel T.F. Polypeptide growth factors: roles in normal and abnormal cell growth. Ann. Rev. Cell Bid 1987; 3: 443
   PubMedGoogle Scholar
• Heldin C.H., Westemark B. Platelet-derived growth factor: mechanism of action and possible in viva function. Cell Regulation 1990; 1: 555–566
   PubMedGoogle Scholar
• Sporn MI.B., Roberts A.B., Wakefield L.M., Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell. Bid 1987; 105: 1039–1045
   PubMed Web of Science ®Google Scholar
• Oka Y., Orth D.N. Human plasma epidermal growth factor/β-urogastrone is associated with blood platelets. J. Clin. Invest. 1983; 72: 249–259
   PubMed Web of Science ®Google Scholar
• Hammacher A., Hellman U., Johnsson A., Östman A., Gunnarson K., Westermark B., Wasteson A., Heldin C.-H. A major part of platelet derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J. Biol. Chem 1988; 263: 16493–16498
   PubMed Web of Science ®Google Scholar
• Rao C.H., Igarashi H., Chiu I.M., Robbins K.C., Aaronson S.A. Structure anti sequence of the human c-sis/platelet-de-rived growth factor 2 (SIS/PDGF 2) transcriptional unit. Proc. Natl. Acad, Sci. U.S.A. 1986; 83: 2392–2396
   PubMed Web of Science ®Google Scholar
• Betsholtz C., Hohnsson A., Heldin C.-H., Westermark B., Urdea M.S., Eddy R., Shows T.B., Philpott Mellor K., I- A., Knott T.J., Scott J. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its ex-pression in tumor cell lines. Nature 1986; 320: 695–699
   PubMed Web of Science ®Google Scholar
• Bonthron D.T., Morton C.C., Orkin S.H., Collins T. Platelet derived growth factor A chan: gene structure, chromosomal location. arid basis for alternative mRNA splicing. Proc. Natn. Acad. Sci. U.S.A. 1986; 85: 1492–1496
   Web of Science ®Google Scholar
• Katoh Kimura O.A., Itoh T., Kuramoto A. Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am. J. Hematol. 1990; 35: 145–150
   PubMed Web of Science ®Google Scholar
• Alitalo R., Andersson L.C., Betsholtz C., Nilason K., Westermark B., Heldin C.-H., Alitalo K. Induction of platelet-derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines. EMBO J 1987; 16: 1213–1218
   Google Scholar
• Papayannopoulou T.H., Raines E., Collins S., Nakamoto B., Tweeddale M., Ross R. Constitutive and inducible secretion of platelet derived growth factor analogs by human leukemic cell lines, coexpressing erythroid and megakaryocytic markers. J. Clin Invest. 1987; 79: 859–866
   PubMed Web of Science ®Google Scholar
• Oatman A, Rall L., Hammacher A., Wormstead M.A., Coit D., Valenzuela P., Betsholtz C., Westermark B., Heldin C.-H. Synthesis and assembly of a functionally active recombinant platelet-derived growth factor AB heterodimer. J. Biol. Chem. 1988; 263: 16202–16208
   PubMed Web of Science ®Google Scholar
• Huang J.S., Huang S.S., Deuel T.F. Human platelet-derived growth factor: radioimmunoassay and discovery of a specific plasma-binding protein. J. Cell. Biol 1983; 97: 383–388
   PubMed Web of Science ®Google Scholar
• Senior R.M., Huang J.S., Kimura A., Griffin G.L., Deuel T.F. Platelet-granule protein-induced chemotaxis of inflammatory cells and fibroblasts. Methods Enzymol 1989; 169: 233–244
   PubMed Web of Science ®Google Scholar
• Paulsson Y., Hammacher A., Heldin C.-H., Westermark B. Possible positive autocrine feedback in the prereplicative phase of human fibroblasts. Nature 1987; 328: 715–717
   PubMed Web of Science ®Google Scholar
• Nister M., Hammacher A., Mellström K., Siegbahn A., Rönnstrand L., Westermark B., Heldin C.-H. A glioma-derived PDGF A chain homodimer has different functional activities from PDGF AB heterodimer purified from human platelets. Cell 1988; 52: 791–799
   PubMed Web of Science ®Google Scholar
• Yarden Y., Exobedo J A, Kuang W.J., Feng Yaig T.L., Daniel T.O., Tremble P.M., Chen E.Y., Ando M.E., Harkins R.N., Francke V., Fried A., Ullric A., Williams L.T. Structure of the receptor from platelet-derived growth factor receptors. Nature 1986; 323: 226–232
   PubMed Web of Science ®Google Scholar
• Matsui T., Heideran M., Miki T., Popescu N., La Rochelle W., Kraus M., Pierce J., Aronson S.A. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 1989; 243: 800–804
   PubMed Web of Science ®Google Scholar
• Hart C.E, Forstrom J.W., Kelly J.D., Smith R.A., Ross P., Murray Bowen– M.J., Pope D.F. Two classes of PDGF receptor recognize different isoforms of PDGF. Science 1988; 240: 1529–1531
   PubMed Web of Science ®Google Scholar
• Heldin C-H., Backstrom G., Ostman A., Hammacher A., Ronnstrand L., Rubin K., Nister M., Westermark B. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separated receptor types. EMBO J. 1988; 7: 1387–1393
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming frowth factor-β on the growth of human marrow fibroblasts. Br. J. Haematol 1988; 69: 9–12
   PubMed Web of Science ®Google Scholar
• Williams L.T. Signal transduction by the platelet-derived growth factor, receptor. Science l989; 243: 1564–1570
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Rabellino E.M., Yen A., Nachman R.L., Moore M.A.S. Human megakkaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 1981; 57: 781–787
   PubMed Web of Science ®Google Scholar
• Katoh O., Kimura A., Kuramoto A. Platelet derived growth factor (PDGFI is decreased in patients with myeloproliferative disorders. Am. J. Hematol. 1988; 27: 276–280
   PubMed Web of Science ®Google Scholar
• Gersuk G.M., Carmel R., Pattengale P.K. Platelet-de- rived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood 1989; 74: 2330–2334
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Gay R.E., Resnick G., Napoor N., Meyers P., Chiarieri D., McKenzie S., Broxrneyer H.E., Moore A.S. Characterization of human bone marrow fibroblast colony ferming cells (CFU-F) and their progeny. Blood. 1980; 56: 289–301; 1980
   PubMed Web of Science ®Google Scholar
• Kimura Karoli A., Hyodo O.H., Kuramoto A. Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol. 1989; 72: 486–341
   PubMed Web of Science ®Google Scholar
• Battegay J.E., Kuines W.E., Seifert Bowen- A.R., Pope F.D., Ross R. TGF induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515–524
   PubMed Web of Science ®Google Scholar
• Ignotz R.A., Maaaague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their in-corporation into the extracellular matrix. J. Biol. Chem. 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Ignotz R.A., Endo T., Massage J. Regulation of fibronectin and type I collagen mRNA level by transforming growth factor β. J Biol. Chem. 1987; 262: 6443–6446
   PubMed Web of Science ®Google Scholar
• Kimura Katoh A.O., Hyodo H., Kusumi S., Kuramoto A. Fibroblast colony forming cells with high sensitivity to serum mitogen(s) exit in bone marrow of patents with chronic myelocytic leukemia. Eur J. Haematol 1990; 44: 291–195
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Marrow fibroblasts from patient with myeloproliferative disorders show increased sensitivity to human serum mitogens. Br. J. Haematol. 1988; 69: 53–156
   Google Scholar
• Castro-Malaspina H., Gay R.E., Jhanwar S.C., Hamilton J.A., Chiarieri D.R., Meyers P.A., Gay S., Moore M.A.S. Characteristics of bone marrow fibroblast colony-forming cell (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 1982; 59: 104–1054
   Google Scholar
• Bettelheim P., Lutz D., Majdic O., Paietta Haas E., Linkesch O., Neummann E., Lechner K., Knapp W. Cell lineage heterogenity in blast crisis of chronic myeloid leukaemia. Br. J. Haematol. 1985; 59: 395–409
   PubMed Web of Science ®Google Scholar
• SanMiguel J.F., Tavares de Castro J., Matutes E., Rodriguez B., Polli N., Zola H., McMichael A.J., Bollum F.J., Thompson D.S., Goldman J.M., Catovsky D. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukemias. Br. J. Haematol. 1985; 59: 297–309
   PubMed Web of Science ®Google Scholar
• Kimura A., Nakata Y., Hyodo H., Kuramoto A., Satow Y. Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogeneous leukaemia with myelofibrosis. Br. J. Haematol. 1994; 86: 303–307
   PubMed Web of Science ®Google Scholar
• Laiho M., Keski-Oja J. Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res. 1989; 49: 25–33
   PubMedGoogle Scholar
• Kimura A., Katoh O., Hyodo H., Kusumi S., Kuramoto A. Autocrine and/or paracrine mechanism operate during the growth of human bone marrow fibroblasts. Br. J. Haematol. 1991; 78: 469–473
   PubMed Web of Science ®Google Scholar
• Petrini M., Cecconi N., Azzara A., Ambrogi F., Grassi B. 1,26-Dihydroxy-vitamin D3 (1,25(OH)2,D3) in the treatment of idiopathic meylofibrosis. Br. J. Haematol. 1986; 64: 624–625
   PubMed Web of Science ®Google Scholar
• Richard C., Mazorra F., Iriondo A., Mazo E., Bello C., Zubizarreta A. The usefulness of 1,25-dihydroxy-vitamin D3 (1,25(OH)2 vit D3) in the treatment of idiopathic myelofibrosis. Br. J. Huemalol. 1986; 62: 399–400
   PubMed Web of Science ®Google Scholar
• Hyodo H., Kimura A., Nakata Y., Ohta H., Kuramoto A. l α-Hydroxy vitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts. International J. Hematol. 1993; 57: 131–137
   PubMed Web of Science ®Google Scholar